Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 May;149(5):2423-32.
doi: 10.1210/en.2007-0830. Epub 2008 Feb 7.

Ovarian steroids stimulate adenosine triphosphate-sensitive potassium (KATP) channel subunit gene expression and confer responsiveness of the gonadotropin-releasing hormone pulse generator to KATP channel modulation

Affiliations

Ovarian steroids stimulate adenosine triphosphate-sensitive potassium (KATP) channel subunit gene expression and confer responsiveness of the gonadotropin-releasing hormone pulse generator to KATP channel modulation

Wenyu Huang et al. Endocrinology. 2008 May.

Abstract

The ATP-sensitive potassium (K(ATP)) channels couple intracellular metabolism to membrane potential. They are composed of Kir6.x and sulfonylurea receptor (SUR) subunits and are expressed in hypothalamic neurons that project to GnRH neurons. However, their roles in regulating GnRH secretion have not been determined. The present study first tested whether K(ATP) channels regulate pulsatile GnRH secretion, as indirectly reflected by pulsatile LH secretion. Ovariectomized rats received sc capsules containing oil, 17beta-estradiol (E(2)), progesterone (P), or E(2)+P at 24 h before blood sampling. Infusion of the K(ATP) channel blocker tolbutamide into the third ventricle resulted in increased LH pulse frequency in animals treated with E(2)+P but was without effect in all other groups. Coinfusion of tulbutamide and the K(ATP) channel opener diazoxide blocked this effect, whereas diazoxide alone suppressed LH. Effects of steroids on Kir6.2 and SUR1 mRNA expression were then evaluated. After 24hr treatment, E(2)+P produced a modest but significant increase in Kir6.2 expression in the preoptic area (POA), which was reversed by P receptor antagonism with RU486. Neither SUR1 in the POA nor both subunits in the mediobasal hypothalamus were altered by any steroid treatment. After 8 d treatment, Kir6.2 mRNA levels were again enhanced by E(2)+P but to a greater extent in the POA. Our findings demonstrate that 1) blockade of preoptic/hypothalamic K(ATP) channels produces an acceleration of the GnRH pulse generator in a steroid-dependent manner and 2) E(2)+P stimulate Kir6.2 gene expression in the POA. These observations are consistent with the hypothesis that the negative feedback actions of ovarian steroids on the GnRH pulse generator are mediated, in part, by their ability to up-regulate K(ATP) channel subunit expression in the POA.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Representative profile of pulsatile LH release (A) in OVX, 24-h vehicle-treated rats and comparison of mean LH pulse frequency (B), mean LH pulse amplitude (C), and mean LH level (D) before, during, and after icv infusion of 200 μm tolbutamide (n = 4). Asterisks denote pulses determined by ULTRAGUIDE pulse analysis software. The black bar indicates the time when tolbutamide was infused into the third ventricle.
Figure 2
Figure 2
Representative profile of pulsatile LH release (A) in OVX, 24-h E2-treated rats and comparison of mean LH pulse frequency (B), mean LH pulse amplitude (C), and mean LH level (C) before, during, and after icv infusion of 200 μm tolbutamide (n = 5). Asterisks denote pulses determined by ULTRAGUIDE pulse analysis software. The black bar indicates the time when tolbutamide was infused into the third ventricle.
Figure 3
Figure 3
Representative profile of pulsatile LH release (A) in OVX, 24-h E2+P-treated rats and comparison of mean LH pulse frequency (B), mean LH pulse amplitude (C), and mean LH level (D) before, during, and after icv infusion of 200 μm tolbutamide (n = 5). Asterisks denote pulses determined by ULTRAGUIDE pulse analysis software. The black bar indicates the time when tolbutamide was infused into the third ventricle. *, P < 0.05 vs. before and after.
Figure 4
Figure 4
Representative profile of pulsatile LH release (A) in OVX, 24-h E2+P-treated rats and comparison of LH pulse frequency (B), pulse amplitude (C), and mean LH level (D) before, during, and after icv infusion of 300 μm diazoxide plus 200 μm tolbutamide (n = 7). Asterisks denote pulses determined by ULTRAGUIDE pulse analysis software. The black bar indicates the time when the drugs were infused into the third ventricle. *, P < 0.05 before vs. after.
Figure 5
Figure 5
Representative profile of pulsatile LH release (A) in OVX, 24-h E2+P-treated rats and comparison of LH pulse frequency (B), pulse amplitude (C), and mean LH level (D) before, during, and after icv infusion of 300 μm diazoxide (n = 6). Asterisks denote pulses determined by ULTRAGUIDE pulse analysis software. The black bar indicates the time when diazoxide was infused into the third ventricle. *, P < 0.05 before vs. during.
Figure 6
Figure 6
Comparison of Kir6.2 and SUR1 subunit mRNA expression in the POA (A and B) and MBH (C and D) in OVX, 24-h vehicle- (C), E2-, P-, E2+P-, or E2+P+RU486 (R)-treated rats (n = 5 or 6 for each group). E2+P significantly up-regulated Kir6.2 mRNA expression in the POA (*, P < 0.05), which was reversed by RU486. SUR1 mRNA expression in the POA was not affected by any steroid treatment. Neither subunit in the MBH was affected by estrogen and/or progesterone.
Figure 7
Figure 7
Comparison of Kir6.2 and SUR1 mRNA expression in the POA (A and B) and MBH (C and D) in OVX, 8-d vehicle- (C), E2-, P-, or E2+P-treated rats (n = 8 for each group). In the POA, E2+P significantly increased Kir6.2 mRNA expression compared with vehicle (*, P < 0.05), whereas E2 or P alone had no significant effects on Kir6.2 mRNA expression. SUR1 subunit expression levels in the POA were not different among different treatment groups. In the MBH, E2+P significantly increased (*, P < 0.05) SUR1 subunit expression compared with vehicle and E2. Kir6.2 subunit expression in MBH was not altered by any steroid treatment.
Figure 8
Figure 8
LH levels after 8-d steroid treatments. E2 and E2+P treatment significantly reduced LH levels compared with vehicle and P treatment. Groups with different letters are significantly different from each other. P < 0.05, E2 vs. P; P < 0.001, C vs. E2, C vs. E2+P, and P vs. E2+P.

Similar articles

Cited by

References

    1. Levine JE, Ramirez VD 1982 Luteinizing hormone-releasing hormone release during the rat estrous cycle and after ovariectomy, as estimated with push-pull cannulae. Endocrinology 111:1439–1448 - PubMed
    1. Goodman RL, Daniel K 1985 Modulation of pulsatile luteinizing hormone secretion by ovarian steroids in the rat. Biol Reprod 32:217–225 - PubMed
    1. Chabbert-Buffeta N, Skinner DC, Caraty A, Bouchard P 2000 Neuroendocrine effects of progesterone. Steroids 65:613–620 - PubMed
    1. Leipheimer RE, Bona-Gallo A, Gallo RV 1985 Ovarian steroid regulation of pulsatile luteinizing hormone release during the interval between the mornings of diestrus 2 and proestrus in the rat. Neuroendocrinology 41:252–257 - PubMed
    1. Couse JF, Korach KS 1999 Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20:358–417 - PubMed

Publication types

MeSH terms